BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 11207821)

  • 1. Precursor lesions of ovarian epithelial malignancy.
    Feeley KM; Wells M
    Histopathology; 2001 Feb; 38(2):87-95. PubMed ID: 11207821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detailed morphology of human ovarian surface epithelium focusing on its metaplastic and neoplastic capability.
    Okamura H; Katabuchi H
    Ital J Anat Embryol; 2001; 106(2 Suppl 2):263-76. PubMed ID: 11732586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precursors and pathogenesis of ovarian carcinoma.
    Lim D; Oliva E
    Pathology; 2013 Apr; 45(3):229-42. PubMed ID: 23478230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different proportions of aneusomic cells in ovarian inclusion cysts associated with serous borderline tumours and serous high-grade carcinomas support different pathogenetic pathways.
    Körner M; Burckhardt E; Mazzucchelli L
    J Pathol; 2005 Sep; 207(1):20-6. PubMed ID: 16021676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology of ovarian cancer precursors.
    Scully RE
    J Cell Biochem Suppl; 1995; 23():208-18. PubMed ID: 8747398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition.
    Piek JM; Verheijen RH; Menko FH; Jongsma AP; Weegenaar J; Gille JJ; Pals G; Kenemans P; van Diest PJ
    Histopathology; 2003 Jul; 43(1):26-32. PubMed ID: 12823709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal to epithelial transition in the human ovarian surface epithelium focusing on inclusion cysts.
    Okamoto S; Okamoto A; Nikaido T; Saito M; Takao M; Yanaihara N; Takakura S; Ochiai K; Tanaka T
    Oncol Rep; 2009 May; 21(5):1209-14. PubMed ID: 19360296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies.
    Salazar H; Godwin AK; Daly MB; Laub PB; Hogan WM; Rosenblum N; Boente MP; Lynch HT; Hamilton TC
    J Natl Cancer Inst; 1996 Dec; 88(24):1810-20. PubMed ID: 8961970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward understanding the natural history of ovarian carcinoma development: a clinicopathological approach.
    Horiuchi A; Itoh K; Shimizu M; Nakai I; Yamazaki T; Kimura K; Suzuki A; Shiozawa I; Ueda N; Konishi I
    Gynecol Oncol; 2003 Mar; 88(3):309-17. PubMed ID: 12648580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 protein expression in putative precursor lesions of epithelial ovarian cancer.
    Hutson R; Ramsdale J; Wells M
    Histopathology; 1995 Oct; 27(4):367-71. PubMed ID: 8847068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
    Shappell HW; Riopel MA; Smith Sehdev AE; Ronnett BM; Kurman RJ
    Am J Surg Pathol; 2002 Dec; 26(12):1529-41. PubMed ID: 12459620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian mucinous and mixed epithelial carcinomas of mullerian (endocervical-like) type: a clinicopathologic analysis of four cases of an uncommon variant associated with endometriosis.
    Lee KR; Nucci MR
    Int J Gynecol Pathol; 2003 Jan; 22(1):42-51. PubMed ID: 12496697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis.
    Dehari R; Kurman RJ; Logani S; Shih IeM
    Am J Surg Pathol; 2007 Jul; 31(7):1007-12. PubMed ID: 17592266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the histogenesis and morphology of ovarian carcinomas.
    Dallenbach-Hellweg G
    J Cancer Res Clin Oncol; 1984; 107(2):71-80. PubMed ID: 6715398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two types of ovarian cortical inclusion cysts: proposed origin and possible role in ovarian serous carcinogenesis.
    Banet N; Kurman RJ
    Int J Gynecol Pathol; 2015 Jan; 34(1):3-8. PubMed ID: 25473746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal changes in magnetic resonance imaging of malignant and borderline tumors associated with ovarian endometriotic cyst comparing with endometriotic cysts without arising malignancy.
    Nishio N; Kido A; Kataoka M; Kuwahara R; Nakao K; Kurata Y; Matsumura N; Mandai M; Togashi K
    Eur J Radiol; 2018 Aug; 105():175-181. PubMed ID: 30017276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural changes and cell properties of human ovarian surface epithelium in ovarian pathophysiology.
    Okamura H; Katabuchi H; Nitta M; Ohtake H
    Microsc Res Tech; 2006 Jun; 69(6):469-81. PubMed ID: 16718660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current concepts in ovarian epithelial tumorigenesis: correlation between morphological and molecular data.
    Scott M; McCluggage WG
    Histol Histopathol; 2006 Jan; 21(1):81-92. PubMed ID: 16267789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathology of epithelial ovarian cancer.
    Christie M; Oehler MK
    J Br Menopause Soc; 2006 Jun; 12(2):57-63. PubMed ID: 16776856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Müllerian Mucinous Cystadenomas of the Ovary: A Report of 25 Cases of an Unheralded Benign Ovarian Neoplasm Often Associated With Endometriosis and a Brief Consideration of Neoplasms Arising From the Latter.
    Watkins JC; Young RH
    Int J Gynecol Pathol; 2022 Jan; 41(1):68-75. PubMed ID: 33577227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.